| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer
1 company
Alka Chaubey is Chief Medical Officer at BNGO. Alka Chaubey's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $744 at current prices.
Alka Chaubey has 15 Form 4 filings on record from September 2020 to June 2026, all as Chief Medical Officer at Bionano Genomics (BNGO), 2020–2026.
The 18 reported transactions were 8 option or other derivative awards, 7 tax withholdings and 3 stock awards.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria